Printer-friendly versionSend to friend
The promise of scientific partnership:
UM/Israel Partnership for Research
Medical science is progressing at an exponentially increasing rate, but the process of turning that progress into new treatments and cures for our most devastating diseases lags behind. To keep pace with rapid change and address increasingly challenging problems, scientists must reach across disciplinary and national boundaries. The new era of science requires a novel way of doing research: one that is bold in spirit, innovative in its collaboration and global in approach.
Israel is home to some of the world’s most advanced scientific and technical research. Israel produces more start-up companies than Japan, China, India, Korea, Canada and the UK. Per person, the country has attracted more than twice the venture capital investment as the United States. Furthermore, Israel has more companies on the NASDAQ stock exchange than any country outside the U.S. and leads the world in medical device patents.
The University of Michigan is a world-class research university, and within U-M, the Life Sciences Institute (LSI) is the home of leading work in genetics, stem cells, drug discovery, and disease initiatives addressing diabetes, cancer and infectious diseases. The LSI’s partner in the UM/Israel collaboration, the U-M Cardiovascular Center, conducts scientific research and delivers top-notch care to patients. U-M is actively engaged in supporting translational research and business engagement through a variety of university-wide entrepreneurial initiatives and has the resources to provide business, legal and regulation advising to promising ideas.
The alliance between University of Michigan and scientists in Israel has already accelerated the development of new medications and treatments, but there is untapped potential.
The U-M/Israel Partnership for Research will connect great minds across political borders. Working in a new way, at the edges of the disciplines and without limitations of national or academic boundaries, scientists will be empowered to pursue the most promising approaches to confront some of humanity’s most serious health concerns.
The UM/Israel Partnership for Research creates important new scientific opportunities and interactions. Access to Israeli stem cell lines allows U-M scientists to further expand their research in this critical and promising area. In exchange, Israeli universities gain access to U-M’s scientific and clinical research assets, including LSI’s Center for Chemical Genomics, one of only a handful of campus-based chemical screening facilities for early-stage drug discovery. The Partnership also creates significant collaborative opportunities for both U-M and Israeli students.
The potential for new discovery is great, but support is scarce. Few traditional funding sources are available for scientists who want to collaborate across existing boundaries. The U-M/Israel Partnership for Research provides the necessary support to catalyze ground-breaking discovery.
UM/Israel Partnership for Research: FAQs
What are the goals of the UM/Israel Partnership for Research?
- Accelerate scientific discovery though collaborative research and exchange between scientists at U-M and Israeli universities.
- Leverage the combined resources and expertise of U-M and Israeli universities to accomplish more than the institutions could alone.
- Provide comprehensive scientific learning and training opportunities for U-M and Israeli students, fellows and faculty.
How will those goals be accomplished?
Fosters innovative, disease-based projects involving both U-M and Israeli research teams. Projects will be selected on a competitive basis and might explore problems such as cancer, heart disease or diabetes.
Student and Faculty Research Exchange
The international exchange of students, fellows and faculty from U-M and Israeli universities. These research-based exchanges typically last at least one academic semester, in order to ensure meaningful immersion.
Joint meetings between U-M and Israeli scientists to share discoveries and knowledge. These interactions catalyze collaborations between scientists for future study.
Joint ventures would give the Partnership the opportunity to develop deeper resources in some research areas capitalizing on the strengths that exist at specific institutions and enabling faculty at other institutions to benefit from these strengths. The Partnership is positioned to nurture start-up companies around the most promising ideas and products that are generated in the labs.
To learn more, contact:
Director of Major Gifts